zlacker

>>giulio+(OP)
Yet they seem to be spending more in restaurants:

> Ozempic Users Actually Spend More Dining Out.

> ..In casual dining establishments, they spend 25% more than non-GLP-1 households do, the market researcher says. Data firm Numerator shares similar findings, noting that while GLP-1 users report eating out less and cooking at home more, their spending says otherwise: “Verified purchase data reveals that their fast-food buy rate is up 2%.”

https://www.bloomberg.com/news/articles/2026-01-02/ozempic-g... (archive: https://archive.ph/V6Erv)

>>helsin+89
Wow, it's hard to think of a better example of a correlational study measuring something that would obviously be confounded by the thing being studied. Don't forget that most GLP-1 users are obese and many will continue to be after treatment (as it only causes a reduction in 10%-20% of body weight). And they're rich. So the headline is "rich obese people spend more in restaurants than average".

No shade on people taking the drug btw. I'm on tirzepatide myself.

>>ChadNa+7o2
Do we know what the reason is for the limits of around 10-20%?

>>fireca+Ho2
I don't know that there's a consensus on what the limit really is. Semaglutide is good for about 15%, tirzepatide about 20%, and retatrutide about 25%. Some people don't get that much, some people get a lot more. Personally, tirzepatide got me just over 35%. I never got anywhere near max dose, either, I am what is colloquially referred to as a super responder.